Register
Register
Register

Project cooperationUpdated on 27 January 2026

Improvement of quality of life in elderly patients with diffuse large B-cell lymphoma

Professor at Lund University

Lund, Sweden

About

POLAR BEAR is a randomized phase 3 trial of 300 patients comparing R-mini-CHOP and pola-R-mini CHP in patients with aggressive B-cell lymphoma >80 years, or frail 75-80 years. HRQOL is evaluated by EORTC-QLQ-C30 at baseline and during the trial.

Topic

  • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients

Type

  • Consortium/Coordinator seeks Partners

Organisation

Lund University

University

Lund, Sweden

Similar opportunities

  • Project cooperation

    Facilitating contacts with cancer researchers at Medical University of Vienna

    • Completing the consortia
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-02: Microbiome for early cancer prediction before the onset of disease
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Reinhard Eckert

    Research Service at Medical University of Vienna

    Vienna, Austria

  • Project cooperation

    Clinical research to evaluate the impact of Meditation and Yoga on health and as therapeutic supports.

    • Offering Expertise to Consortias
    • Design - setting the project scope
    • Consortium/Coordinator seeks Partners
    • Ideation - identifying the project idea
    • HORIZON-MISS-2026-02-CANCER-04: Earlier and more precise palliative care
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-05: Boosting mental health of young cancer survivors through the European Cancer Patient Digital Centre (ECPDC)

    Paolo Pacciolla

    Freelancer at Muni Sangha

    Pavia, Italy

  • Project cooperation

    Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    • Offering Expertise to Consortias
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Javier Carmona

    Head of Scientific Strategy at Vall d'Hebron Institute of Oncology

    BARCELONA, Spain